Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA Hoppe, R. T. 1989; 3 (2): 265-276

Abstract

Patients with Hodgkin's disease who have a large mediastinal mass present a challenge to the oncologist. Individualized therapy is often a key consideration for the management of these patients. Careful clinical staging is essential to develop the most effective treatment plan. The majority of these patients may be treated most effectively with combined modality therapy; however, a carefully selected group may be treated successfully with irradiation alone. Close follow-up is helpful to detect early relapse or manage complications of therapy.

View details for Web of Science ID A1989U560600007

View details for PubMedID 2663827